ScienceLogic Launches Industry-First Context Infused AIOps Platform
ScienceLogic, a leader in providing IT operations with actionable insights from IT operational data, today announced the launch of ScienceLogic SL1, its new, industry-defining AIOps platform.
IT operations is the last great frontier in search of resilient digital experiences. For modern Ops, keeping pace in an increasingly ephemeral world exceeds human cognition, where application and infrastructure workloads traverse multi-cloud architectures and rapidly transition technology landscapes. To thrive, Ops must retool itself, ready to support the demands for service agility, onboarding of new lines of business and ongoing M&A.
Enter ScienceLogic SL1, which was designed and developed with the specific goal of leveling the playing field between the pace at which Dev can create great digital experiences, and the ability of Ops to make them resilient experiences.
“Ten years ago, we saw enterprises moving to a state of ephemeral operations, motivated by speed and agility. It started at the infrastructure layer but evolved quickly towards DevOps movements emphasizing service development and rapid release. Today’s performance management systems must provide operational insights in real-time derived from a deep understanding of dependency mapping between applications and their underlying infrastructure,” said ScienceLogic CEO, Dave Link.
SL1 understands how mission-critical applications connect to the underlying infrastructure by deriving topology maps, which enable real-time service health views that inform, analyze and act. This context allows businesses to bring meaning across various data silos and generate insights that drive automated actions like never before.
“As IBM continues to grow our ecosystem around the IBM Services Platform with Watson, it is critical we work with other leading companies who can assist in delivering solutions that augment human intelligence to help improve service provider operations and free up professionals to focus on driving higher value results,” said Bridget Karlin, IBM Services CTO and Vice President of Technology, Innovation & Automation. “In working with ScienceLogic to utilize AI to help enterprises predictively ensure IT success before business services are impacted, we are better enabling our clients to create a resilient digital experience.”
ScienceLogic SL1 Core Capabilities
- See – Automated real-time discovery inclusive of applications and infrastructure across IT silos and multi-cloud environments
- Contextualize - Automated topology maps to establish real-time relationships between disparate data sets bringing context to data
- Act - Automated issue discovery and subsequent remediation across a diverse range of technologies including CMDB (Configuration Management Database), DevOps and APM (Application Performance Management)
SL1 Innovative Technologies at Work
- PowerMap – If context is king for AIOps, PowerMap is what provides that context. PowerMap creates a multi-dimensional topological map of dependencies in real-time between all components and across all layers of technology - providing immediate context to the underlying raw data. This becomes a crucial input source for Machine Learning engines to provide actionable insights and automations.
- PowerSync – If automation is the endgame of AIOps, PowerSync is the engine that powers it. By providing a universal communication bridge to get data in, share data out and keep data synchronized, PowerSync breaks down the data silos that currently limit automation. It provides multi-directional and intelligent data transformations asynchronously and concurrently among any number of platforms. PowerSync completes the story with a powerful automation engine to enact change to the environment.
Early Customer Feedback
“Our partnership with ScienceLogic plays a key part in our expanding digital workplace offering, ensuring resilient customer experiences through intelligent discovery, data normalization and proactive management of edge to data center services,” said Norihisa Takayama, General Manager for Digital Workplace at Konica Minolta. "Within Workplace Hub, our scalable IT ecosystem that helps organisations orchestrate their physical and digital resources, SL1 provides service health visibility through automated discovery of IoT edge devices to service cognition via real-time ephemeral application to infrastructure mapping. In addition, SL1 can analyze and connect millions of metrics per second, enabled by a horizontally scalable NoSQL architecture and a topology-based analytics engine. This enables automated root cause analysis, proactive remediation, and smart provisioning to millions of edge devices via our AI enabled management platform.”
“Flexential is a long-time partner of ScienceLogic, focused on helping customers optimize their IT transformation journey,” said Jim Parks SVP, Central Operations at Flexential. "ScienceLogic’s SL1 will help us become more competitive and address new opportunities by creating new advanced services that combine business service visibility with applications and infrastructure views - while giving our operations team greater levels of automation to help us deliver outstanding service quality.”
“T-Systems is solving major enterprise challenges by partnering with ScienceLogic,” said Thorsten Meyer, Product Manager at T-Systems. “ScienceLogic SL1 helps enterprises to manage business services cost-effectively. Through real-time Business dashboards, our customers can understand application and service health across the underlying transient infrastructure of clouds, microservices, and containers. The unified business service, applications and infrastructure visibility in ScienceLogic SL1 will enable us to create compelling new managed services for business-critical functions.”
“Modern IT systems — with their modularity, dynamism, and distributedness — require a multi-perspective approach even to understand what is happening as they are being observed, let alone to project their future or to determine the causes that got them to where they are. Hence, enterprises should select those AIOps platforms that are capable of ingesting and analyzing data from a multiplicity of sources.”
- Gartner Market Guide for AIOps Platforms, August 2017
ScienceLogic recorded a video podcast with Forrester Principal Analyst Charles Betz, who discussed the importance of Cognitive Ops and Information Management:
“There have been some real limitations with how we’ve approached the problem of infrastructure management. You have silos of data in the CMDB, APM, log managers, and aggregation, end-user experience monitoring and more. But it’s not really being effectively brought together, let alone with the human-to-human telemetry. We need cognitive operations in a closely human-partnered way to enable operators to dig down very quickly [...] and pursue specific hypothesis in real-time and at high-tempo in high-consequence situations.”
- Charles Betz, Forrester
ScienceLogic is a leader in IT Operations Management, providing modern IT operations with actionable insights to resolve and predict problems faster in a digital, ephemeral world. Its solution sees everything across cloud and distributed architectures, contextualizes data through relationship mapping, and acts on this insight through integration and automation. Trusted by thousands of organizations, ScienceLogic’s technology was designed for the rigorous security requirements of United States Department of Defense, proven for scale by the world’s largest service providers, and optimized for the needs of large enterprises.
Sage Communications (for ScienceLogic)
Brian Kelley, 703-533-1618
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
AURAK Gains SACSCOC Accreditation15.12.2018 10:49 | Pressemelding
The Southern Association of Colleges and Schools Commission on Colleges (SACSCOC) officially announced the accreditation of the American University of Ras Al Khaimah (AURAK) at its 2018 Annual Meeting which was held in New Orleans, Louisiana, in the United States of America. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181215005017/en/ AURAK delegation during the SACSCOC conference in New Orleans” (Photo: AETOSWire) SACSCOC, the regional body for the accreditation of degree-granting higher education institutions in the Southern United States, has a membership of more than 800 institutions in the Southern states and other international sites approved by SACSCOC that award associate, baccalaureate, master’s, and/or doctoral degrees. SACSCOC also awards accreditation to other international institutions of higher education that satisfy all its requirements and demonstrate compliance with its accreditation standards. AURAK now
Lehman Brothers Treasury Announces Plans for Partial Wind-Down14.12.2018 17:41 | Pressemelding
Lehman Brothers Treasury Co. B.V. in liquidation (“LBT”) today, through its U.S. counsel Kramer Levin Naftalis & Frankel LLP, announced that LBT is planning a final cash distribution to its creditors. Professional holders of eligible notes will have the option to retain their investment by electing to receive substitute notes of one (or a few) series. Such election shall take place through a solicitation process. As a consequence, LBT will be able to reduce the number of series of notes outstanding from more than 3,700 to one or a few. Noteholders electing to receive substitute notes will be afforded the same economic entitlement to distributions received by LBT from Lehman Brothers Holdings Inc. (“LBHI”) through the substitute notes. The substitute notes will be denominated in U.S. dollars and future distributions will be made in U.S. dollars only. Noteholders who are not professional investors, or hold notes that are not eligible for substitution, or do not elect to receive substitut
Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD14.12.2018 17:00 | Pressemelding
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for the extension of the marketing authorization of ADCETRIS (brentuximab vedotin) and recommended its approval in combination with AVD in adult patients with previously untreated CD30+ Stage IV Hodgkin lymphoma. ADCETRIS is an antibody-drug conjugate (ADC) directed at CD30, a defining marker of Hodgkin lymphoma. ADCETRIS is currently not approved as a therapy for previously untreated Hodgkin lymphoma in Europe. “For a large number of previously untreated Hodgkin lymphoma patients diagnosed with Stage IV disease, progression will occur with current treatments, highlighting a true unmet need in this population,” said Anna Sureda, M.D., Ph.D., Head of the Hematology Department and Hematopoietic Stem Cell Transplant Programme, Institut Català d'Oncologia - Hospital Duran i Reynals. “In the ECHELON-1 cl
Diamond CBD, POTN Subsidiary, Enters the $46 Billion Coffee Market With the Release of Premium Line of CBD-Infused Coffee & Tea K-Kup Capsules14.12.2018 15:42 | Pressemelding
Diamond CBD Inc., wholly owned subsidiary of PotNetwork Holdings, Inc. (OTC Pink: POTN), a leader in hemp extraction and innovative CBD products for the wellness market, enters the Coffee segment, an industry expected to reach revenues of $46 Billion in 2018. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181214005308/en/ Experience a cup of Chill (Photo: Business Wire) Produced in accordance with a universal K-Cup design, these pods fit in almost all modern single cup coffee makers, making it an easily integrated enhancement to any environment, delivering 25mgs of CBD in a tasty favorite beverage at less than $5 per cup. This new line of premium Chill Coffee Capsules was recently added to the Company’s broad range of cannabinoid and natural hemp products. Each box comes with 4 individual capsules in original chill coffee, decaf chill coffee, chill black tea, and chill green tea flavors. The unit price for each box is $10.00
Henley & Partners Enlarges Executive Committee to Manage Expansion and Growth14.12.2018 14:00 | Pressemelding
Residence- and citizenship-by-investment programs have firmly established themselves over the past few years as the new frontier in terms of freedom, flexibility, and future-readiness, both for the countries issuing these programs and for the individual investors participating in them. The societal and economic value these programs generate is undisputed. The investment migration industry as a whole is currently grossing roughly USD 18 billion per year, with an expectation that it will hit the USD 20 billion mark very soon. Foreign direct investment (FDI) is now considered the lifeblood of economic growth for many developing and recovering smaller countries around the world. As such, the number of investment migration programs has been increasing rapidly, from just a handful of programs in the 1980s and 1990s to over 100 countries that now have investment migration provisions in their laws. There are more than 60 active programs today, with Moldova and Montenegro — both fast-growing Eu
Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer14.12.2018 09:07 | Pressemelding
Boehringer Ingelheim announced today the first interim results of VARGADO, an ongoing non-interventional study in routine clinical practice in Germany evaluating the efficacy and safety of Vargatef® (nintedanib) and docetaxel in patients with stage III/IV locally advanced or metastatic non-small cell lung cancer (NSCLC) of adenocarcinoma histology. The study consists of three cohorts, two of which allow for prior treatment with immune checkpoint inhibitors (ICIs) either in combination with chemotherapy in the first-line or as monotherapy in the second-line of treatment. The interim results from Cohort B (first-line chemotherapy, second-line immune checkpoint inhibitors, third-line Vargatef® plus docetaxel) were presented today at ESMO Immuno-Oncology Congress 2018 in Geneva.1 Despite a limited sample size, the VARGADO study adds to the body of evidence for nintedanib in lung adenocarcinoma following pre-treatment with chemotherapy and ICIs.1,3 The addition of nintedanib to docetaxel ha